Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural Mesothelioma

NCT06875076 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Pretreated Pleural Mesothelioma

Interventions

DRUG: Ivonescimab Combined With Chemotherapy

Sponsor

The First Hospital of Jilin University